192 related articles for article (PubMed ID: 30054639)
1. Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns.
Flint RB; Ter Heine R; Spaans E; Burger DM; de Klerk JCA; Allegaert K; Knibbe CAJ; Simons SHP
Eur J Clin Pharmacol; 2018 Dec; 74(12):1585-1591. PubMed ID: 30054639
[TBL] [Abstract][Full Text] [Related]
2. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
Gouyon JB; Kibleur Y
Clin Ther; 2010 Sep; 32(10):1740-8. PubMed ID: 21194597
[TBL] [Abstract][Full Text] [Related]
4. Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates.
Samiee-Zafarghandy S; van Donge T; Fusch G; Pfister M; Jacob G; Atkinson A; Rieder MJ; Smit C; Van Den Anker J
Arch Dis Child; 2022 Jan; 107(1):86-91. PubMed ID: 33975823
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: intravenous Ibuprofen in preterm newborns.
Aranda JV; Thomas R
Semin Perinatol; 2006 Jun; 30(3):114-20. PubMed ID: 16813969
[TBL] [Abstract][Full Text] [Related]
6. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
[TBL] [Abstract][Full Text] [Related]
7. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
8. Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?
Smit C; Engbers AGJ; Samiee-Zafarghandy S; van Donge T; Simons SHP; Flint RB; Pfister M; Knibbe CAJ; van den Anker JN
Neonatology; 2023; 120(1):81-89. PubMed ID: 36502794
[TBL] [Abstract][Full Text] [Related]
9. Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?
Akar M; Yildirim TG; Sandal G; Bozdag S; Erdeve O; Altug N; Uras N; Oguz SS; Dilmen U
Cardiol Young; 2017 Apr; 27(3):507-511. PubMed ID: 27319277
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.
Dani C; Poggi C; Mosca F; Schena F; Lista G; Ramenghi L; Romagnoli C; Salvatori E; Rosignoli MT; Lipone P; Comandini A
Trials; 2016 Apr; 17():182. PubMed ID: 27038924
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
Heo MJ; Lee OS; Lim SC
Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
[TBL] [Abstract][Full Text] [Related]
12. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure.
Roofthooft DW; van Beynum IM; de Klerk JC; van Dijk M; van den Anker JN; Reiss IK; Tibboel D; Simons SH
Eur J Pediatr; 2015 Nov; 174(11):1433-40. PubMed ID: 25922139
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic strategies for the treatment of patent ductus arteriosus in preterm infants.
Dani C
J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():5-6. PubMed ID: 21815877
[TBL] [Abstract][Full Text] [Related]
14. Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen.
Cristea S; Allegaert K; Falcao AC; Falcao F; Silva R; Smits A; Knibbe CAJ; Krekels EHJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182538
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two dose regimens of ibuprofen for the closure of patent ductus arteriosus in preterm newborns.
Dornelles LV; Corso AL; Silveira Rde C; Procianoy RS
J Pediatr (Rio J); 2016; 92(3):314-8. PubMed ID: 26946966
[TBL] [Abstract][Full Text] [Related]
16. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
Adamska E
Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
[TBL] [Abstract][Full Text] [Related]
17. Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus.
Engbers AGJ; Flint RB; Völler S; de Klerk JCA; Reiss IKM; Andriessen P; Liem KD; Degraeuwe PLJ; Croubels S; Millecam J; Allegaert K; Simons SHP; Knibbe CAJ
Br J Clin Pharmacol; 2020 Oct; 86(10):2028-2039. PubMed ID: 32250464
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oral and intravenous Ibuprofen for medical closure of patent ductus arteriosus: which one is better?
Olukman O; Calkavur S; Ercan G; Atlihan F; Oner T; Tavli V; Kultursay N
Congenit Heart Dis; 2012; 7(6):534-43. PubMed ID: 22613269
[TBL] [Abstract][Full Text] [Related]
19. Ibuprofen in the management of neonatal Patent Ductus Arteriosus.
Keady S; Grosso A
Intensive Crit Care Nurs; 2005 Feb; 21(1):56-8. PubMed ID: 15681219
[TBL] [Abstract][Full Text] [Related]
20. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.
Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2015 Mar; (3):CD010061. PubMed ID: 25758061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
